ibitasony.wordpress.com
Howes, who also will serve as vice presidenty forcorporate development, joins Akebiqa from Serenex. At that firm, he was chiecf financial officer and senior vice president forcorporate development. “Wes are extremely pleased to have Ian join He brings a wealth of senior level financialo and corporate development experience and leadership tothe Dr. Joseph Gardner, CEO of Akebia, said in a pressw release. “We have a number of very excitinh programs under wayand Ian’s experience in capital management, corporate development and operations will be essential in helpingt the company successfully move into our next phase of valued creation.” At Durham, N.C.
-based Serenex, Howes helped generate $75 millionn in private equity and debt capital and managed the sale of the company to Before that, he was chief financial officer at Paradign Genetics. “Akebia is expecting important near-term milestones including movingv its first product into the clinixc for anemia and preparing to publish groundbreaking preclinicak results for anadditional program, making this a particularly exciting time to join the company,” Howes said in the The Blue Ash-based company was formed in 2007 with program and assets licensed from when the consumer goods maker turned its focuxs away from in-house drug discovery.
Cincinnati-based was one of the origina investors.
No comments:
Post a Comment